D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 52 Citations 28,945 114 World Ranking 11812 National Ranking 5050

Overview

What is he best known for?

The fields of study Hisashi Harada is best known for:

  • Gene
  • Apoptosis
  • Transcription factor

Cell biology and Stem cell are frequently intertwined in his study. His Stem cell study frequently links to other fields, such as Cell biology. His Genetics study frequently links to adjacent areas such as Cell growth. Hisashi Harada performs integrative study on Gene and Transfection. His work blends Transfection and Gene studies together. Biochemistry and Phosphorylation are commonly linked in his work. In his works, he performs multidisciplinary study on Phosphorylation and Protein kinase A. His multidisciplinary approach integrates Protein kinase A and Kinase in his work. His Kinase study frequently draws connections between adjacent fields such as Biochemistry.

His most cited work include:

  • Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL (2503 citations)
  • Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin (1969 citations)
  • Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements (940 citations)

What are the main themes of his work throughout his whole career to date

Other disciplines of study, such as Catalysis and Sonochemistry, are mixed together with his Organic chemistry studies. Hisashi Harada combines Catalysis and Organic chemistry in his research. He integrates Gene and Gene expression in his studies. In his articles, he combines various disciplines, including Gene expression and Gene. Hisashi Harada combines Biochemistry and Enzyme in his studies. Hisashi Harada integrates Enzyme and Biochemistry in his research. While working on this project, he studies both Genetics and Molecular biology. While working in this field, he studies both Molecular biology and Genetics. Cell biology is closely attributed to Kinase in his work.

Hisashi Harada most often published in these fields:

  • Gene (51.64%)
  • Biochemistry (44.26%)
  • Genetics (36.07%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (81.25%)
  • Gene (56.25%)
  • Cancer (56.25%)

In recent works Hisashi Harada was focusing on the following fields of study:

Hisashi Harada merges Cancer research with Lung cancer in his research. His Lung cancer study frequently links to related topics such as Oncology. In his works, Hisashi Harada undertakes multidisciplinary study on Oncology and Cancer research. He undertakes multidisciplinary studies into Gene and Cisplatin in his work. Cisplatin and Apoptosis are two areas of study in which he engages in interdisciplinary work. He performs integrative study on Apoptosis and Downregulation and upregulation in his works. He performs integrative study on Downregulation and upregulation and Gene in his works. While working on this project, Hisashi Harada studies both Cancer and Cell culture. Hisashi Harada performs integrative study on Cell culture and Cancer.

Between 2015 and 2021, his most popular works were:

  • Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination (91 citations)
  • Tumor cell escape from therapy-induced senescence (87 citations)
  • Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression (73 citations)

In his most recent research, the most cited works focused on:

  • Cancer
  • Chemotherapy
  • Gene

Phenotype and Druggability are closely tied to his Gene research. In his articles, he combines various disciplines, including Cancer research and Lung cancer. Hisashi Harada performs multidisciplinary studies into Lung cancer and Small-cell carcinoma in his work. His Small-cell carcinoma study typically links adjacent topics like Small Cell Lung Carcinoma. His research links Internal medicine with Small Cell Lung Carcinoma. Internal medicine and Oncology are two areas of study in which Hisashi Harada engages in interdisciplinary research. He undertakes multidisciplinary investigations into Oncology and Cancer research in his work. By researching both Cancer and Immunology, Hisashi Harada produces research that crosses academic boundaries. Hisashi Harada undertakes interdisciplinary study in the fields of Immunology and Cancer through his works.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)

8302 Citations

Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL

Jiping Zha;Hisashi Harada;Elizabeth Yang;Jennifer Jockel.
Cell (1996)

3362 Citations

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

Toshio Hirano;Kiyoshi Yasukawa;Hisashi Harada;Tetsuya Taga.
Nature (1986)

2680 Citations

Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements

Masaaki Miyamoto;Takashi Fujita;Yoko Kimura;Mitsuo Maruyama.
Cell (1988)

1159 Citations

Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes

Hisashi Harada;Takashi Fujita;Masaaki Miyamoto;Yoko Kimura.
Cell (1989)

1141 Citations

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

R. Kamijo;H. Harada;T. Matsuyama;Maarten C. Bosland.
Science (1994)

1043 Citations

Phosphorylation and Inactivation of BAD by Mitochondria-Anchored Protein Kinase A

Hisashi Harada;Brian Becknell;Matthias Wilm;Matthias Mann.
Molecular Cell (1999)

809 Citations

p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

Hisashi Harada;Jens S. Andersen;Matthias Mann;Naohiro Terada.
Proceedings of the National Academy of Sciences of the United States of America (2001)

667 Citations

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1

Nobuyuki Tanaka;Masahiko Ishihara;Motoo Kitagawa;Hisashi Harada.
Cell (1994)

613 Citations

Anti-Oncogenic and Oncogenic Potentials of Interferon Regulatory Factors-1 and -2

Hisashi Harada;Motoo Kitagawa;Nobuyuki Tanaka;Hitomi Yamamoto.
Science (1993)

559 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hisashi Harada

Tadamitsu Kishimoto

Tadamitsu Kishimoto

Osaka University

Publications: 108

Toshio Hirano

Toshio Hirano

National Institutes for Quantum and Radiological Science and Technology

Publications: 86

Tadatsugu Taniguchi

Tadatsugu Taniguchi

University of Tokyo

Publications: 81

Steven Grant

Steven Grant

Virginia Commonwealth University

Publications: 69

Andreas Strasser

Andreas Strasser

Walter and Eliza Hall Institute of Medical Research

Publications: 67

Paul Dent

Paul Dent

Virginia Commonwealth University

Publications: 61

John Hiscott

John Hiscott

McGill University

Publications: 46

Stefan Rose-John

Stefan Rose-John

Kiel University

Publications: 43

David C. S. Huang

David C. S. Huang

Walter and Eliza Hall Institute of Medical Research

Publications: 40

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 39

James A. McCubrey

James A. McCubrey

East Carolina University

Publications: 37

Keiko Ozato

Keiko Ozato

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publications: 33

Peter C. Heinrich

Peter C. Heinrich

University of Freiburg

Publications: 33

Hong-Gang Wang

Hong-Gang Wang

Pennsylvania State University

Publications: 31

Douglas R. Green

Douglas R. Green

St. Jude Children's Research Hospital

Publications: 31

Paula M. Pitha

Paula M. Pitha

Johns Hopkins University

Publications: 30

Trending Scientists

Ganesh Ananthanarayanan

Ganesh Ananthanarayanan

Microsoft (United States)

Enrique Oñate

Enrique Oñate

Spanish National Research Council

Yaoming Xie

Yaoming Xie

University of Georgia

Claudio Pellecchia

Claudio Pellecchia

University of Salerno

Ying Tian

Ying Tian

Dalian Maritime University

Arpan Chakraborty

Arpan Chakraborty

Apple (United States)

Pablo V. Gejman

Pablo V. Gejman

NorthShore University HealthSystem

Maud C. O. Ferrari

Maud C. O. Ferrari

University of Saskatchewan

María del Mar Delgado

María del Mar Delgado

Spanish National Research Council

Valerie J. Harwood

Valerie J. Harwood

University of South Florida

Clint Chapple

Clint Chapple

Purdue University West Lafayette

Margareta Ieven

Margareta Ieven

University of Antwerp

Maria Rosaria Capobianchi

Maria Rosaria Capobianchi

National Institutes of Health

Karl-Dieter Opp

Karl-Dieter Opp

Leipzig University

Ryan Shannon

Ryan Shannon

Swinburne University of Technology

Olivier Bienaymé

Olivier Bienaymé

University of Strasbourg

Something went wrong. Please try again later.